Turkey, Russia reach agreement on S-400 air defense system deliveriesMilitary & Defense April 28, 13:38
Night rehearsal of Victory Day ParadeMilitary & Defense April 28, 13:31
Merkel to discuss Ukrainian crisis, Syria with PutinWorld April 28, 13:25
Press review: Putin, Abe talk Kurils and Kiev to call Crimea, Donbass 'Russian-occupied'Press Review April 28, 13:00
Russia’s Airborne Force to get advanced anti-tank missile systemsMilitary & Defense April 28, 12:37
OPCW ready to send experts to Syria’s Khan Sheikhoun, chief saysWorld April 28, 12:33
Engine failure stalls Renault car of Russia’s Sirotkin at F1 Sochi GP practiceSport April 28, 12:30
Russian state arms seller delivers modern weaponry worth over $10 bln to Latin AmericaMilitary & Defense April 28, 12:09
Prosecutor demands blogger get 3.5-year jail term for ‘catching Pokemon’ in churchSociety & Culture April 28, 11:51
GENEVA, June 14. /TASS/. The Court of Arbitration for Sport announced on Tuesday that it would announce its decision regarding an appeal from Russian tennis player Maria Sharapova before July 18.
According to various media reports earlier in the day, tennis star Sharapova has filed an appeal with the CAS in Switzerland’s Lausanne against her two-year suspension, which was imposed last week by the International Tennis Federation’s (ITF) Tribunal over anti-doping violations.
"In her appeal to the CAS, Ms Sharapova seeks the annulment of the Tribunal’s decision to sanction her with a two-year period of ineligibility further to an anti-doping rule violation," the CAS said in its statement. "Ms Sharapova submits that the period of ineligibility should be eliminated, or in the alternative, reduced."
"The parties have agreed to an expedited procedure which will allow the CAS to render a decision, at the latest, on 18 July 2016," the statement added.
In early March, Sharapova announced that her doping tests revealed the presence of performance enhancing drug meldonium in the body system. Following the announcement, former World’s No. 1 was provisionally suspended from all tennis-related activities.
The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
WADA announced on April 13 that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.